Mahbanoo Farhadi-Azar

Dr. Mahbanoo Farhadi-Azar

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2023 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
MFMahbanoo Farhadi-Azar
Mahbanoo Farhadi-Azar
MNM. Noroozzadeh
M. Noroozzadeh
MGM. Ghahremani
M. Ghahremani
MRM. Rahmati
M. Rahmati
MNM. Saei Ghare Naz
M. Saei Ghare Naz
FTF. Ramezani Tehrani
F. Ramezani Tehrani

30 May 2022 in International Journal of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
MDMarzieh Rostami Dovom
Marzieh Rostami Dovom
MNMahsa Noroozzadeh
Mahsa Noroozzadeh
NMNariman Mosaffa
Nariman Mosaffa
Abbas PiryaeiAbbas Piryaei
Abbas Piryaei
AZAzita Zadeh-Vakili
Azita Zadeh-Vakili
FTFahimeh Ramezani Tehrani
Fahimeh Ramezani Tehrani
Background: Embryonic life is critical for the formation of ovaries in mammals, and the intrauterine environment may affect ovarian reserve. Objectives: The present study aimed to investigate the impact of prenatal D-galactose exposure on ovarian reserve in female rat offspring in their later lives. Methods: Ten pregnant Wistar rats were randomly divided into two groups. In one group, rats were fed with 35% D-galactose-enriched food from the third day to the end of pregnancy, and in the other group, rats were fed with a standard diet throughout pregnancy. Female offspring (prenatally galactose-exposed rats and non-exposed control rats) were examined in terms of hormonal levels [anti-Mullerian hormones (AMH), follicle-stimulating hormone (FSH), and estradiol (E2)] and ovarian histology at 45 - 50, 105 - 110, and 180 - 185 days of their age. Results: The number of primordial follicles significantly decreased time-dependently in prenatally galactose-exposed rats compared to controls (P-value = 0.002). In addition, decreases in AMH (3.25 vs. 7.5 ng/mL; P = 0.000) and E2 (7.9 vs. 19.5 pg/mL; P = 0.000) and increases in FSH (6.5 vs. 0.8 mIU/mL; P < 0.007) were observed in galactose-exposed rats compared to controls at 45 - 50 days of age. Conclusions: Prenatal exposure to D-galactose negatively affects ovarian reserve in female rats in their later lives. However, further investigation is needed to confirm our findings and explore underlying mechanisms.

29 April 2023 in International Journal of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
MFMahbanoo Farhadi-Azar
Mahbanoo Farhadi-Azar
MNMarzieh Saei Ghare Naz
Marzieh Saei Ghare Naz
MGMehrdad Ghahremani
Mehrdad Ghahremani
MMMaryam Mousavi
Maryam Mousavi
FAFereidoun Azizi
Fereidoun Azizi
FTFahimeh Ramezani Tehrani
Fahimeh Ramezani Tehrani
Background: Male infertility is a growing health problem. It is proposed that infertility is associated with some metabolic abnormalities. Objectives: This study aimed to examine the prevalence of self-reported male infertility and related metabolic disturbances. Methods: This is a cross-sectional analysis of the Tehran Lipid and Glucose Study (TLGS). A total of 1526 males participated in the study. Logistic regression was used to examine metabolic factors associated with self-reported male infertility. Results: The total prevalence of self-reported male infertility was 6.42%. The mean (SD) body mass index (BMI) of participants among fertile and infertile males was 26.80 (3.93) and 26.92 (4.36), respectively. The majority of participants in both groups were in the age group of 40-50 years old. In the fully adjusted model, the odds of infertility were significantly increased by each unit increase in total cholesterol [TC; odds ratio (OR), 1.01; 95% CI, 1.01 - 1.01; P = 0.03] and hip circumference (HC; OR, 1.06; 95% CI, 1.00 - 1.12; P = 0.02), respectively. Conclusions: The prevalence of self-reported male infertility was 6.42%. Male infertility was positively associated with TC and HC, indicating that knowledge about these risks might assist health care professionals and governments in developing and executing measures to change the status quo.

29 November 2024 in Experimental Physiology
Verified
Journal Article
Open access
MFMahbanoo Farhadi-Azar
Mahbanoo Farhadi-Azar
MNMahsa Noroozzadeh
Mahsa Noroozzadeh
MMMaryam Mousavi
Maryam Mousavi
MNMarzieh Saei Ghare Naz
Marzieh Saei Ghare Naz
FTFahimeh Ramezani Tehrani
Fahimeh Ramezani Tehrani
Polycystic ovary syndrome (PCOS), one of the most common endocrine disorders in reproductive‐aged women, is associated with metabolic disturbances. The present study aimed to examine changes in body weight (BW) and glucose and insulin tolerance in a prenatally‐androgenized (PNA) rat model of PCOS compared to control with increasing age. Pregnant rats in the experimental group were subcutaneously injected with 5 mg of free testosterone on the 20th day of pregnancy, while the control group received the solvent. Female offspring of both groups, PNA rats (rat model of PCOS) and control, were examined in terms of changes in BW, glucose and insulin tolerance at 3, 6, 12 and 20 months of age. BW at birth (6.53 ± 0.89 vs. 5.60 ± 1.18 g; P = 0.038), 15 (25 ± 1.15 vs. 22.36 ± 3.98 g; P = 0.019) and 30 (59.37 ± 10.19 vs.49.9 ± 9.39 g; P = 0.022) days of age was significantly increased in the rat model of PCOS compared to control, but no significant differences were observed in BW of the rat model of PCOS compared to control at 60 (P = 0.155) and 75 (P = 0.932) days or at 3 (P = 0.239), 6 (P = 0.782), 12 (P = 0.755) and 20 (P = 0.092) months of age. Rat model of PCOS showed impaired glucose tolerance (IGT) at 3 months of age (P = 0.020) and insulin resistance (IR) with increasing age (3–20 months of age) compared to control. Increased BW before puberty, IGT at 3 months of age and IR with increasing age were observed in our rat model of PCOS. This rat model may contribute to a better understanding of underlying mechanisms of changes in BW, IGT and IR in future studies.

31 January 2026 in International Journal of Endocrinology and Metabolism
Verified
Journal Article
Open access
MNMahsa Noroozzadeh
Mahsa Noroozzadeh
MNMarzieh Saei Ghare Naz
Marzieh Saei Ghare Naz
MMMaryam Mousavi
Maryam Mousavi
MFMahbanoo Farhadi-Azar
Mahbanoo Farhadi-Azar
MFMaryam Farahmand
Maryam Farahmand
FTFahimeh Ramezani Tehrani
Fahimeh Ramezani Tehrani
Context: Polycystic ovary syndrome (PCOS) affects an increasing number of reproductive-aged women and has been progressively associated with a spectrum of metabolic disturbances. Understanding its long-term cardiometabolic consequences, both in affected women and in their offspring, is critical for informing early prevention and targeted intervention strategies. This study provides a comprehensive synthesis of published data from the Tehran lipid and glucose study (TLGS) on women with PCOS, offering insights into epidemiological patterns, risk factors, and potential intergenerational impacts in this population. Evidence Acquisition: This narrative review provides a comprehensive summary of TLGS-based publications addressing cardiometabolic disorders associated with PCOS. Relevant studies were identified through a comprehensive search of PubMed (including Medline), Web of Science, and Scopus. Results: Data from the TLGS indicate a rising prevalence of PCOS over approximately a decade, increasing from 8.5% based on the National Institutes of Health (NIH) criteria to 13.6% (NIH), 17.8% (androgen excess (AE)-PCOS Society), and 19.4% (Rotterdam criteria). Women with PCOS in early adulthood demonstrated elevated levels of insulin resistance (IR) as reflected by higher HOMA-IR and fasting insulin values, and subsequently experienced a heightened likelihood of developing type 2 diabetes mellitus (T2DM), hypertension, metabolic syndrome (MetS), and obesity, with adjusted hazard ratios ranging from approximately 0.58 to 2.08 across multiple publications. Notably, the prevalence of certain cardiometabolic disorders appeared to decline after the age of 40 years. Longitudinal data showed that trajectories of HOMA-IR and fasting insulin differed depending on obesity status in women with PCOS, and that cardiometabolic risk burden varied across diagnostic phenotypes. Interestingly, PCOS was not associated with an increased risk of silent coronary artery disease. Nevertheless, the Framingham risk score (FRS) showed good predictive performance for cardiovascular disease (CVD) in the PCOS population, with a 38% increase in CVD risk per 1-unit increment in FRS among affected women. Intergenerational analyses further highlighted that the offspring of women with PCOS carry a higher predisposition to metabolic disorders. Daughters of affected women were found to have increased risks of T2DM, overweight, and MetS. At the same time, sons exhibited significantly elevated risk of pre-diabetes mellitus, with adjusted hazard ratios ranging from approximately 1.3 to 2.4. These findings underscore both the individual and transgenerational cardiometabolic disorders of PCOS. Conclusions: Publications from the TLGS provide consistent evidence that PCOS is associated with a spectrum of early cardiometabolic disturbances in affected women with potential adverse impacts extending to their offspring. These observations underscore the importance of implementing age-specific metabolic screening and preventive interventions for women with PCOS and their offspring. Furthermore, they highlight the need for long-term, prospective follow-up studies to elucidate underlying causal pathways and identify targeted strategies for timely intervention.

31 January 2026 in International Journal of Endocrinology and Metabolism
Verified
Journal Article
Open access
MFMaryam Farahmand
Maryam Farahmand
MMMaryam Mousavi
Maryam Mousavi
MNMarzieh Saei Ghare Naz
Marzieh Saei Ghare Naz
MFMahbanoo Farhadi-Azar
Mahbanoo Farhadi-Azar
MNMahsa Noroozzadeh
Mahsa Noroozzadeh
FTFahimeh Ramezani Tehrani
Fahimeh Ramezani Tehrani
Context: Understanding the different reproductive factors and their link to non-communicable diseases (NCDs) is crucial in a community-based cohort study. The present study provides a comprehensive synthesis of published findings derived from the Tehran lipid and glucose study (TLGS) pertaining to women, offering insights into the epidemiological patterns of reproductive lifespan and its impact on cardiometabolic parameters. Evidence Acquisition: We conducted a thorough review of all studies on reproductive lifespan conducted within the TLGS framework. Results: Overall, the mean (SD) age at menarche among participants was 13.35 (1.5) years, whereas the mean (SD) age at menopause was 50.16 (5.7) years. Early menarche was identified as a significant factor associated with later metabolic impairments, including higher odds of prediabetes (OR: 2.7; 95% CI: 1.1 - 6.6), type 2 diabetes mellitus (DM) (OR: 3.6; 95% CI: 1.2 - 10.7), and metabolic syndrome (MetS) (OR: 2.3; 95% CI: 1.1 - 5.4) in fully adjusted models. Comparisons between surgical and natural menopause revealed that the incidence of MetS was nearly tenfold higher among women who experienced surgical menopause, accompanied by elevated mean fasting plasma glucose (FPG) and 2‑hour post‑load glucose concentrations. Furthermore, each additional year in age at natural menopause was associated with a 10% increase in the incidence of chronic kidney disease (CKD), whereas prolonged exposure to endogenous estrogen appeared to confer protective effects, reducing the incidence of hypertension, cardiovascular disease (CVD), CKD, and osteoporotic fractures. In addition, lactation was found to markedly lower the risk of MetS among women with a prior history of gestational diabetes, emphasizing its potential long‑term cardiometabolic benefits. Conclusions: The reproductive milestones significantly shape women’s long‑term cardiometabolic health, supporting the integration of reproductive history into preventive care models and longitudinal risk assessment frameworks.